Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen
Go back to Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 215.25 -1.53 (0.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $216.78 | 52 Week High | $333.65 | |||
| Open | $216.40 | 52 Week Low | $223.02 | |||
| Day High | $217.00 | P/E | 27.56 | |||
| Day Low | $213.96 | EPS | $7.81 | |||
| Volume | 163,260 | |||||
| (NASDAQ: IONS) | Delayed: 61.15 +1.41 (2.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.74 | 52 Week High | $62.68 | |||
| Open | $60.54 | 52 Week Low | $19.59 | |||
| Day High | $61.27 | P/E | N/A | |||
| Day Low | $59.70 | EPS | $0.00 | |||
| Volume | 621,645 | |||||
